CommercialCoverageMedium impact
05.00.81a, Osteogenic Stimulators (non-invasive, invasive/semi-invasive, electrical and ultrasound)
Independence Blue Cross·Orthopedics·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross has reissued policy 05.00.81a covering osteogenic stimulators (non-invasive, invasive/semi-invasive, electrical and ultrasound) with updates effective April 2, 2025. This is a commercial policy update that may affect coverage criteria or documentation requirements for bone growth stimulation devices.
Action Required
By April 2, 2025: Billing team must review the updated osteogenic stimulator policy at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation standards. Update billing procedures and inform orthopedic providers of any new requirements for bone growth stimulator claims to Independence Blue Cross commercial plans.